Disorders of Lipid Metabolism and Micronutrients

Citation:
 
Study Design:
Class:
- Click here for explanation of classification scheme.
Quality Rating:
Research Purpose:

To establish the reliability of a dietary protocol for the assessment of salt-sensitivity involving dietary salt depletion and repletion in normotensive subjects.

Inclusion Criteria:

Healthy males aged 20 to 31 years old; diastolic pressure less than 85mm Hg and systolic pressure less than 140mm Hg

Exclusion Criteria:

None specified

Description of Study Protocol:

Recruitment

Volunteers; no further information provided

Design

In Part 1, each participant was given a low-salt diet plus a 190mmol supplement for seven days followed by a low-salt diet for seven days. A sub-set of participants underwent a randomized crossover trial of dietary salt loading and depletion.

Blinding used

  • In Part 2, participants were blind to which arm of the dietary protocol they were in
  • Those collecting the data do not appear to have been blinded.

Intervention

  • Part 1
    • Low-salt diet (standardized diet-20mmol sodium; kcal per day estimated to keep body weight constant) given for 14 days; during the first seven days 190mmol NaCl added to diet; diet provided by the study and consumed in outpatient setting.
  • Part 2
    • Low-salt diet, as above, with and without supplement of 200mmol per day, for seven days each in random sequence (cross-over study).

Statistical Analysis

  • Mean ± standard error of the mean (SEM)
  • Two-sided Student T-test to compare means
  • Kappa statistics to assess reliability of salt-sensitivity classification
  • Fischer test to assess relationship between familial history and salt-sensitivity.

 

Data Collection Summary:

Timing of Measurements

Measurements of blood pressure taken after a 30-minute resting period on days seven and 14 for both Part 1 and 2 of the study; blood pressure was measured over a one-hour period at two-minute intervals.

 

Dependent Variables

  • Systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, heart rate
    • Blood pressure was measured after a 30-minute rest period at two-minute intervals over the course of an hour using an automatic oscillometric device.

Independent Variables

 Dietary sodium intake, high and low

Control Variables

 Urinary sodium excretion was monitored to assure compliance with the diet

Description of Actual Data Sample:

 

Initial N

Part 1, 40 young men; Part 2, 20 young men

Attrition (final N)

Part 1, 34 young men; Part 2, 15 young men

Age

Ages 20 to 31 years old

Ethnicity

No information; in Part 2, 10 had positive family histories of hypertension and 10 did not.

Other relevant demographics

No information

Anthropometrics

No information. The paper indicates there were no differences in age or body-mass-index between the subjects with positive family histories of hypertension and those without.

Location

Berlin, Germany

 

Summary of Results:

Part 1

Salt-sensitivity was defined as a having a decrease in 3mm Hg or more between the average of the 30 blood pressure readings taken between the high- and low-salt periods.

  • 13 of 19 subjects with positive familial histories were classified as salt-sensitive
  • Three of 15 subjects with negative familial histories were classified as salt-sensitive. (P<0.01)

Part 2 

Mean arterial blood pressure fell from 83.2±2.3 to 77.6±2.8 (P<0.001) mm Hg under the low-salt diet in the salt-sensitive group but was unaffected in the salt-resistant group (high salt 79.0±2.3 vs. low-salt 79.1±2.6mm Hg)

  • All of the persons identified as salt-sensitive in Part 1 were again identified as salt-sensitive in Part 2
  • One of the persons identified as salt-resistant in Part 1 was identified as salt-sensitive in Part 2
  • The reliability of classification was very strong (kappa statistic 0.87)
  • Changes in blood pressure in Part 1 were not significantly correlated for either the salt-sensitive nor the salt-resistant group.
Author Conclusion:

The authors concluded that salt-sensitivity can be reliably tested in normotensive subjects using the dietary protocol specified here. They further concluded that salt-sensitivity is related to a familial history of hypertension.

The authors suggest that the lack of correlation between the blood pressure changes in the two parts of the study may be due to the different order of the dietary regimens.

Funding Source:
University/Hospital: Universitatsklinikum Steglitz, Freie Universitat Berlin
Reviewer Comments:

There is no explanation of the reason for attrition by six subjects in Part 1. Nor is there any description of the characteristics of those who failed to comply in Part 2.

No information was given about the ethnicity of the subjects. Nor was any information given about how they were recruited. There is no explanation of the reason for attrition by six subjects in Part 1. It is not clear how participants were selected to participate in Part 2 from among those meeting the criteria sought, i.e. salt-sensitivity or resistance. Nor is there any description of the characteristics of those who failed to comply in Part 2. These facts along with the very small sample size, 15, who completed Part 2, make it impossible to judge how pre-existing elements of their genetic make-up or environment may have influenced the outcome of the study.

The statistical analysis of the cross-over design did not address whether the order of the dietary treatments influenced the outcome variables. Therefore it is not clear whether there was carryover from one treatment to the next and whether a seven-day treatment was sufficient to control for this possible influence. In fact, the authors suggest that the lack of correlation between the blood pressure changes in the two parts of the study may be due to the different order of the dietary regimens.

Quality Criteria Checklist: Primary Research
Relevance Questions
  1. Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) N/A
  1. Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) N/A
  2. Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? Yes
  2. Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? Yes
  3. Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? Yes
  3. Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? Yes
  4. Is the intervention or procedure feasible? (NA for some epidemiological studies) Yes
  4. Is the intervention or procedure feasible? (NA for some epidemiological studies) Yes
 
Validity Questions
  1. Was the research question clearly stated? Yes
1. Was the research question clearly stated? Yes
  1.1. Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? Yes
  1.1. Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? Yes
  1.2. Was (were) the outcome(s) [dependent variable(s)] clearly indicated? Yes
  1.2. Was (were) the outcome(s) [dependent variable(s)] clearly indicated? Yes
  1.3. Were the target population and setting specified? Yes
  1.3. Were the target population and setting specified? Yes
  2. Was the selection of study subjects/patients free from bias? ???
2. Was the selection of study subjects/patients free from bias? ???
  2.1. Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? No
  2.1. Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? No
  2.2. Were criteria applied equally to all study groups? ???
  2.2. Were criteria applied equally to all study groups? ???
  2.3. Were health, demographics, and other characteristics of subjects described? No
  2.3. Were health, demographics, and other characteristics of subjects described? No
  2.4. Were the subjects/patients a representative sample of the relevant population? ???
  2.4. Were the subjects/patients a representative sample of the relevant population? ???
  3. Were study groups comparable? N/A
3. Were study groups comparable? N/A
  3.1. Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) N/A
  3.1. Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) N/A
  3.2. Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? ???
  3.2. Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? ???
  3.3. Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) Yes
  3.3. Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) Yes
  3.4. If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? N/A
  3.4. If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? N/A
  3.5. If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) N/A
  3.5. If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) N/A
  3.6. If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? Yes
  3.6. If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? Yes
  4. Was method of handling withdrawals described? No
4. Was method of handling withdrawals described? No
  4.1. Were follow-up methods described and the same for all groups? Yes
  4.1. Were follow-up methods described and the same for all groups? Yes
  4.2. Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) No
  4.2. Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) No
  4.3. Were all enrolled subjects/patients (in the original sample) accounted for? No
  4.3. Were all enrolled subjects/patients (in the original sample) accounted for? No
  4.4. Were reasons for withdrawals similar across groups? ???
  4.4. Were reasons for withdrawals similar across groups? ???
  4.5. If diagnostic test, was decision to perform reference test not dependent on results of test under study? N/A
  4.5. If diagnostic test, was decision to perform reference test not dependent on results of test under study? N/A
  5. Was blinding used to prevent introduction of bias? N/A
5. Was blinding used to prevent introduction of bias? N/A
  5.1. In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? No
  5.1. In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? No
  5.2. Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) No
  5.2. Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) No
  5.3. In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? No
  5.3. In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? No
  5.4. In case control study, was case definition explicit and case ascertainment not influenced by exposure status? N/A
  5.4. In case control study, was case definition explicit and case ascertainment not influenced by exposure status? N/A
  5.5. In diagnostic study, were test results blinded to patient history and other test results? N/A
  5.5. In diagnostic study, were test results blinded to patient history and other test results? N/A
  6. Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? No
6. Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? No
  6.1. In RCT or other intervention trial, were protocols described for all regimens studied? No
  6.1. In RCT or other intervention trial, were protocols described for all regimens studied? No
  6.2. In observational study, were interventions, study settings, and clinicians/provider described? No
  6.2. In observational study, were interventions, study settings, and clinicians/provider described? No
  6.3. Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? ???
  6.3. Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? ???
  6.4. Was the amount of exposure and, if relevant, subject/patient compliance measured? Yes
  6.4. Was the amount of exposure and, if relevant, subject/patient compliance measured? Yes
  6.5. Were co-interventions (e.g., ancillary treatments, other therapies) described? N/A
  6.5. Were co-interventions (e.g., ancillary treatments, other therapies) described? N/A
  6.6. Were extra or unplanned treatments described? N/A
  6.6. Were extra or unplanned treatments described? N/A
  6.7. Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? Yes
  6.7. Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? Yes
  6.8. In diagnostic study, were details of test administration and replication sufficient? No
  6.8. In diagnostic study, were details of test administration and replication sufficient? No
  7. Were outcomes clearly defined and the measurements valid and reliable? Yes
7. Were outcomes clearly defined and the measurements valid and reliable? Yes
  7.1. Were primary and secondary endpoints described and relevant to the question? Yes
  7.1. Were primary and secondary endpoints described and relevant to the question? Yes
  7.2. Were nutrition measures appropriate to question and outcomes of concern? Yes
  7.2. Were nutrition measures appropriate to question and outcomes of concern? Yes
  7.3. Was the period of follow-up long enough for important outcome(s) to occur? ???
  7.3. Was the period of follow-up long enough for important outcome(s) to occur? ???
  7.4. Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? Yes
  7.4. Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? Yes
  7.5. Was the measurement of effect at an appropriate level of precision? Yes
  7.5. Was the measurement of effect at an appropriate level of precision? Yes
  7.6. Were other factors accounted for (measured) that could affect outcomes? No
  7.6. Were other factors accounted for (measured) that could affect outcomes? No
  7.7. Were the measurements conducted consistently across groups? Yes
  7.7. Were the measurements conducted consistently across groups? Yes
  8. Was the statistical analysis appropriate for the study design and type of outcome indicators? Yes
8. Was the statistical analysis appropriate for the study design and type of outcome indicators? Yes
  8.1. Were statistical analyses adequately described and the results reported appropriately? Yes
  8.1. Were statistical analyses adequately described and the results reported appropriately? Yes
  8.2. Were correct statistical tests used and assumptions of test not violated? Yes
  8.2. Were correct statistical tests used and assumptions of test not violated? Yes
  8.3. Were statistics reported with levels of significance and/or confidence intervals? Yes
  8.3. Were statistics reported with levels of significance and/or confidence intervals? Yes
  8.4. Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? N/A
  8.4. Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? N/A
  8.5. Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? N/A
  8.5. Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? N/A
  8.6. Was clinical significance as well as statistical significance reported? Yes
  8.6. Was clinical significance as well as statistical significance reported? Yes
  8.7. If negative findings, was a power calculation reported to address type 2 error? No
  8.7. If negative findings, was a power calculation reported to address type 2 error? No
  9. Are conclusions supported by results with biases and limitations taken into consideration? Yes
9. Are conclusions supported by results with biases and limitations taken into consideration? Yes
  9.1. Is there a discussion of findings? Yes
  9.1. Is there a discussion of findings? Yes
  9.2. Are biases and study limitations identified and discussed? No
  9.2. Are biases and study limitations identified and discussed? No
  10. Is bias due to study's funding or sponsorship unlikely? ???
10. Is bias due to study's funding or sponsorship unlikely? ???
  10.1. Were sources of funding and investigators' affiliations described? No
  10.1. Were sources of funding and investigators' affiliations described? No
  10.2. Was the study free from apparent conflict of interest? ???
  10.2. Was the study free from apparent conflict of interest? ???